Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement. This evidence concerns the gene TMEM119 and early-onset autosomal dominant Alzheimer disease.